Abeona Therapeutics Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $298.65 million, with shareholders equity totaling $159.22 million.
The company employs approximately 1.454 people and operates in the Healthcare sector, within the Biotecnologia industry.
Over the past 12 months, Abeona Therapeutics Inc. reported $5.82 million in revenue, generating net income of $71.18 million.
Key financial metrics include a P/E ratio of 4.20, a price-to-book (P/B) ratio of 1.88, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ABEO.